General
Preferred name
quinidine
Synonyms
QUINIDINE GLUCONATE ()
Quinidine hydrochloride monohydrate ()
Quinidine hydrochloride ()
Chinidin Sodium, Pitayine Sodium, β-quinine Sodium, (+)-quinidine Sodium ()
Chinidin Sodium, Pitayine Sodium, ??quinine Sodium, (+)-quinidine Sodium ()
Quinidine (15% dihydroquinidine) ()
Quinidine sulfate ()
Quinidine hemisulfate hydrate ()
Chinidin Sodium, Pitayine Sodium, ¦Â-quinine Sodium, (+)-quinidine Sodium ()
Quinidine sulfate dihydrate ()
Conquinine ()
NSC-757297 ()
Quinidine mono-d-gluconate ()
Quinatime ()
Gluconic acid quinidine salt ()
Quinalan ()
Duraquin ()
Gluquinate ()
Quinidine monogluconate, d- ()
Quinaglute ()
Dura-tab ()
Quinact ()
Kinidin ()
Pitayine ()
(8r,9s)-quinidine ()
.beta.-quinidine ()
QUINIDINE SULFATE COMPONENT OF AVP-786 ()
Cin-Quin ()
AVP-786 COMPONENT QUINIDINE SULFATE ()
Quinidini sulfas ()
Quinicardine ()
Quinora ()
Quinidine sulfate anhydrous ()
Quinidex extentabs ()
Quinidine sulphate dihydrate ()
NSC-10004 ()
Quinidine, sulfate (2:1) (salt) ()
Quinidine sulphate ()
Quinidine sulphate anhydrous ()
Quinidex ()
Quinidine sulfate hydrate ()
Quinidine-d3 ()
P&D ID
PD002895
CAS
7054-25-3
6151-40-2
6591-63-5
101143-86-6
56-54-2
1267657-68-0
Tags
probe
natural product
drug
available
Approved by
FDA
First approval
1962
1950
Drug Status
investigational
approved
Max Phase
Phase 4
Drug indication
Cardiac Depressant (anti-arrhythmic)
Probe info
Probe type
calculated probe
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Quinidine is a stereoisomer of . It acts as a class I antiarrhythmic agent, blocking the fast inward sodium current (INa).
DESCRIPTION Quinidine is a stereoisomer of . It acts as a class I antiarrhythmic agent, blocking the fast inward sodium current (INa).

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. (GtoPdb)
DESCRIPTION Quinidine is a voltage-gated sodium channel blocker, exhibiting antimuscarinic and antimalarial properties. (BOC Sciences Bioactive Compounds)
DESCRIPTION Conquinine is a Cytochrome P450 2D6 inhibitor. It is a dextrorotatory stereoisomer of quinine extracted from the bark of the Cinchona tree and similar plant species. It is an alkaloid with class 1A antiarrhythmic and antimalarial effects. It also blocks muscarinic and alpha-adrenergic neurotransmission. It stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thus inhibiting the sodium influx required for the initiation and conduction of impulses resulting in an increase of the threshold for excitation and decreased depolarization during phase 0 of the action potential. It acts primarily as an intra-erythrocytic schizonticide through association with the heme polymer (hemazoin) in the acidic food vacuole of the parasite thereby preventing further polymerization by heme polymerase enzyme. (BOC Sciences Bioactive Compounds)
Cell lines
2
Organisms
6
Compound Sets
27
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
Enamine BioReference Compounds
Guide to Pharmacology
JUMP-Target 1 Compound Set
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
Probe Miner (suitable probes)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
88
Properties
(calculated by RDKit )
Molecular Weight
324.18
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
5
Aromatic Ring Count
2
cLogP
3.17
TPSA
45.59
Fraction CSP3
0.45
Chiral centers
5.0
Largest ring
6.0
QED
0.88
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Anti-infection
Apoptosis
Metabolic Enzyme/Protease
Target
Potassium Channel
Sodium Channel
KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4
KCNK1
Parasite
Cytochrome P450
Member status
member
MOA
P-Glycoprotein (MDR-1) Inhibitors
Sodium Channel inhibitor
Sodium Channel blocker
Indication
malaria, atrial fibrillation (AF), ventricular arrhythmias
Disease Area
infectious disease, cardiology
Solubility
0.05 g/100 mL
Source data